Literature DB >> 6277055

B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation.

S J Korsmeyer, G J Elfenbein, C K Goldman, S L Marshall, G W Santos, T A Waldmann.   

Abstract

The pathogenic mechanisms responsible for the hypogammaglobulinemia that occurs in patients who have undergone bone marrow transplantation were studied using peripheral blood lymphocytes in an in vitro immunoglobulin biosynthesis assay. None of the nine marrow recipients between 2 and 15 months after transplantation produced normal amounts of IgG, IgA, or IgM in response to pokeweed mitogen (a T cell-dependent activator). However, three of these same patients responded to Epstein-Barr virus (a helper T cell- independent activator), suggesting that these three possessed responsive B cells. Cocultures of the marrow recipients' lymphocytes with lymphocytes from their respective donors or other normal subjects documented excessive suppressor cell activity in five cases. These suppressor cells frequently had profound activity (greater than 80% suppression of the immunoglobulin synthesis of cocultured normal cells), were predominantly radioresistant, and were T cells in the cases where analyzed. Helper T cell activity for immunoglobulin synthesis was not demonstrable in seven of the nine cases. In addition, four of the patients apparently possessed defective B cells. Although most patients had combined defects of several lymphocyte subpopulations, it appeared that either an isolated helper T cell or isolated B cell deficiency was sufficient to result in altered Ig synthesis. In this regard, two patients had demonstrable helper T cell defects with partially responsive B cells and no excessive suppressor activity. Interestingly, these two patients were experiencing a recurrence of their hypogammaglobulinemia following a period of normalized immunoglobulin levels. Thus, defects within all lymphocytic elements involved in the response and regulation of immunoglobulin synthesis were identified and may contribute to the humoral immunodeficiency which follows marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277055     DOI: 10.1097/00007890-198202000-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

Authors:  I Quinti; A Velardi; S Le Moli; E Guerra; R D'Amelio; P Mastrantonio; M F Martelli; F Aiuti
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

2.  The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.

Authors:  L G Lum; M C Seigneuret; R Storb
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

3.  Functional analysis of CD8 lymphocytes in long-term surviving patients after bone marrow transplantation.

Authors:  M Divine; J P Lecouedic; M F Gourdin; N Oudhriri; M Zohair; T Henni; F Beaujan; J P Vernant; F Reyes; J P Farcet
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

4.  Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.

Authors:  J Mattsson; M Uzunel; M Remberger; L Tammik; B Omazic; V Levitsky; J Z Zou; P Hentschke; O Ringdén
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

5.  Characterization of plasma cell populations at autopsy after human allogeneic bone marrow transplantation.

Authors:  S Cousineau; R Belanger; C Perreault
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

Authors:  J Z Wimperis; M K Brenner; H G Drexler; A V Hoffbrand; H G Prentice
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

7.  White pulp reconstitution after human bone marrow transplantation.

Authors:  A Nakayama; N Hirabayashi; M Ito; K Kasai; M Fujino; M Ohbayashi; J Asai
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.

Authors:  J H Antin; K A Ault; J M Rappeport; B R Smith
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

Review 9.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

10.  Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.

Authors:  H C Rümke; F G Terpstra; M T Roos; J M Vossen; L J Dooren; P T Schellekens; W P Zeijlemaker
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.